FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

325906003: Somatropin(epr) 3.33mg/mL injection solution 1.5mL cartridge (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1763398015 Somatropin(epr) 3.33mg/mL injection solution 1.5mL cartridge (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1775822017 Somatropin(epr) 3.33mg/mL injection solution 1.5mL cartridge en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    323871000077118 somatropine (epr) 3,33 mg/mL, cartouche de 1,5 mL de solution injectable fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    somatropine (epr) 3,33 mg/mL, cartouche de 1,5 mL de solution injectable Is a Product containing somatropin (medicinal product) false Inferred relationship Some
    somatropine (epr) 3,33 mg/mL, cartouche de 1,5 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Human growth hormone recombinant false Inferred relationship Some
    somatropine (epr) 3,33 mg/mL, cartouche de 1,5 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Somatropin(epr) false Inferred relationship Some
    somatropine (epr) 3,33 mg/mL, cartouche de 1,5 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Anterior pituitary hormone false Inferred relationship Some
    somatropine (epr) 3,33 mg/mL, cartouche de 1,5 mL de solution injectable Has manufactured dose form injection false Inferred relationship Some
    somatropine (epr) 3,33 mg/mL, cartouche de 1,5 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Pituitary hormone false Inferred relationship Some
    somatropine (epr) 3,33 mg/mL, cartouche de 1,5 mL de solution injectable Is a Product manufactured as parenteral dose form (product) false Inferred relationship Some
    somatropine (epr) 3,33 mg/mL, cartouche de 1,5 mL de solution injectable Has manufactured dose form Solution for injection false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start